UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000035532 |
|---|---|
| Receipt number | R000040482 |
| Scientific Title | The Influence of Joint Conference on Transfer Adjustment among Collaborating Facilities |
| Date of disclosure of the study information | 2019/01/14 |
| Last modified on | 2025/09/26 10:11:24 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The Influence of Joint Conference on Transfer Adjustment among Collaborating Facilities
Acronym
Collaborative cooperative joint conference study
Scientific Title
The Influence of Joint Conference on Transfer Adjustment among Collaborating Facilities
Scientific Title:Acronym
Collaborative cooperative joint conference study
Region
| Japan |
Condition
Condition
General medical case
Chronic disease
Classification by specialty
| Medicine in general | Geriatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Reduction of period of transference
Shorter hospital stays
Medical cost reduction
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Transfer adjustment period
Hospital stay
Medical bills
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 16 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Inpatient inpatient
Key exclusion criteria
Research participation non-consent
Target sample size
60
Research contact person
Name of lead principal investigator
| 1st name | Takehito |
| Middle name | |
| Last name | Kobayashi |
Organization
saitama Medical University Hospital
Division name
General international medicine
Zip code
350-0495
Address
38 Monohongo, Monoyama-Cho, Iruma-gun
TEL
0492761667
kobatake@saitama-med.ac.jp
Public contact
Name of contact person
| 1st name | Takehito |
| Middle name | |
| Last name | Kobayashi |
Organization
saitama Medical University Hospital
Division name
General international medicine
Zip code
350-0495
Address
38 Monohongo, Monoyama-Cho, Iruma-gun, Saitama, JPN
TEL
0492761667
Homepage URL
kobatake@saitama-med.ac.jp
Sponsor or person
Institute
saitama Medical University
Institute
Department
Personal name
Funding Source
Organization
saitama Medical University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
JPN
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Saitama Medical University Hospital Hospital IRB
Address
38 Monohongo, Monoyama-Cho, Iruma-gun, Saitama, JPN
Tel
049-276-1354
hirb@saitama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
埼玉医科大学病院
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 01 | Month | 14 | Day |
Related information
URL releasing protocol
none
Publication of results
Unpublished
Result
URL related to results and publications
none
Number of participants that the trial has enrolled
70
Results
It contributed to shortening the transfer coordination period.
Results date posted
| 2025 | Year | 09 | Month | 26 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Saitama Medical University Hospital Inpatients
Participant flow
Saitama Medical University Hospital Inpatients
Adverse events
none
Outcome measures
Average length of hospital stay
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 04 | Month | 01 | Day |
Date of IRB
| 2018 | Year | 03 | Month | 31 | Day |
Anticipated trial start date
| 2017 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2019 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2019 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
| 2020 | Year | 03 | Month | 31 | Day |
Date analysis concluded
| 2020 | Year | 08 | Month | 31 | Day |
Other
Other related information
Participation form of the person in charge (physician) and person in charge (social worker and care manager) of related facilities in the patient case conference of our facility.
Management information
Registered date
| 2019 | Year | 01 | Month | 12 | Day |
Last modified on
| 2025 | Year | 09 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040482
